Vedolizumab Beats Infliximab as Second-Line UC Therapy ...Middle East

In patients with ulcerative colitis, vedolizumab outperformed infliximab as a second-line therapy following failure of anti-TNF therapy. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Vedolizumab Beats Infliximab as Second-Line UC Therapy )

Also on site :

• 205 Funny Dares That Will Embarrass Your Whole Crew
• I Tried Pvolve—Here's My Honest Review
• Firefighters save baby after he turns purple; “The worst night of our lives”